ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 172 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2015. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $904 | -100.0% | 19,600 | -58.6% | 0.00% | -80.0% |
| Q4 2021 | $3,986,000 | -38.3% | 47,400 | -33.8% | 0.01% | -37.5% |
| Q3 2021 | $6,458,000 | -85.4% | 71,600 | -84.5% | 0.01% | -85.5% |
| Q2 2021 | $44,090,000 | +167.4% | 462,400 | +219.3% | 0.06% | +161.9% |
| Q1 2021 | $16,487,000 | +25.6% | 144,800 | +52.7% | 0.02% | +50.0% |
| Q4 2020 | $13,123,000 | +281.0% | 94,800 | +74.3% | 0.01% | +100.0% |
| Q1 2016 | $3,444,000 | +1018.2% | 54,400 | +1600.0% | 0.01% | +600.0% |
| Q3 2015 | $308,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |